Se connecter Inscription gratuite

Last updated: 24 June 2024 at 5:06pm EST

Elizabeth Anderson Net Worth




The estimated Net Worth of Elizabeth M Anderson is at least $2.64 million dollars as of 13 October 2020. Ms. Anderson owns over 5,000 units of Insmed Inc stock worth over $1,963,792 and over the last 6 years she sold INSM stock worth over $425,000. In addition, she makes $255,000 as Independent Director at Insmed Inc.

Ms. Anderson INSM stock SEC Form 4 insiders trading

Elizabeth has made over 2 trades of the Insmed Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 5,000 units of INSM stock worth $225,000 on 13 October 2020.

The largest trade she's ever made was selling 5,000 units of Insmed Inc stock on 13 October 2020 worth over $225,000. On average, Elizabeth trades about 500 units every 0 days since 2018. As of 13 October 2020 she still owns at least 26,990 units of Insmed Inc stock.

You can see the complete history of Ms. Anderson stock trades at the bottom of the page.





Elizabeth Anderson biography

Elizabeth McKee Anderson is an Independent Director of the Company. Ms. Anderson has more than 30 years of leadership in biotechnology, pharmaceuticals, and vaccines. From 2003 to 2014, Ms. Anderson held various positions at Janssen Pharmaceuticals, Inc. (“Janssen”), a Johnson & Johnson company. Most recently, from 2013 to 2014, Ms. Anderson served as Worldwide Vice President, Infectious Diseases and Vaccines. Ms. Anderson’s prior positions at Janssen included Worldwide Vice President, Global Strategic Marketing and Market Access (2010 — 2013); Worldwide Vice President, Immunology, Global Strategic Marketing (2008 — 2009); Worldwide Vice President, BIO Strategic Marketing (2006 — 2008); Vice President, Global Biologics Strategic Marketing, Centocor (2004 — 2006); and Vice President, Strategic Planning & Market Research, Centocor (2003 — 2004). From 1997 to 2002, Ms. Anderson served as Vice President & General Manager at Wyeth Lederle Vaccines (“Wyeth”). Prior to Wyeth, Ms. Anderson held various roles at Rhone Poulenc Rorer Pharmaceuticals Inc. and the American National Red Cross. Ms. Anderson currently serves on the Board of Directors of (1) Aro Biotherapeutics Company, a private development stage pharmaceutical company; (2) Bavarian Nordic A/S, a public biotechnology company traded on Nasdaq Copenhagen; (3) Huntsworth PLC, a public healthcare and communications company traded on the London Stock Exchange; and (4) REVOLUTION Medicines, Inc., a private pharmaceutical company focused on oncology. Ms. Anderson received a B.S. in Engineering from Rutgers, the State University of New Jersey and an M.B.A. from Loyola University Maryland. Ms. Anderson has over 30 years of leadership in biotechnology, pharmaceuticals and vaccines. The Board believes that Ms. Anderson's experience, including extensive global marketing and infectious disease experience, makes her well-suited to guide the Board in commercial and market access matters.

What is the salary of Elizabeth Anderson?

As the Independent Director of Insmed Inc, the total compensation of Elizabeth Anderson at Insmed Inc is $255,000. There are 17 executives at Insmed Inc getting paid more, with William Lewis having the highest compensation of $7,175,090.



How old is Elizabeth Anderson?

Elizabeth Anderson is 62, she's been the Independent Director of Insmed Inc since 2018. There are 4 older and 19 younger executives at Insmed Inc. The oldest executive at Insmed Inc is Steinar Engelsen, 70, who is the Independent Director.

What's Elizabeth Anderson's mailing address?

Elizabeth's mailing address filed with the SEC is C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DR, REDWOOD CITY, CA, 94063.

Insiders trading at Insmed Inc

Over the last 22 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis et Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.



What does Insmed Inc do?

insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.



What does Insmed Inc's logo look like?

Insmed Inc logo

Complete history of Ms. Anderson stock trades at Biomarin Pharmaceutical, Insmed Inc et Revolution Medicines Inc

Date
#
Société
 Initié
Trans.
Transaction
 Actions Prix par action Prix ​​total Actions après Source
13 Oct 2020 RVMD Revolution Medicines Inc Elizabeth M Anderson
Vente 5,000 $45.00 $225,000
13 Oct 2020
26,990 ↗
6 Oct 2020 RVMD Revolution Medicines Inc Elizabeth M Anderson
Vente 5,000 $40.00 $200,000
6 Oct 2020
31,990 ↗


Insmed Inc executives and stock owners

Insmed Inc executives and other stock owners filed with the SEC include: